zolgensmas

Display
Industry Focus

Series: Industry Focus

Episode: Healthcare: Is This Highly-Anticipated Gene Therapy In Trouble?

Duration: 22 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Zolgensma Is Helping Babies To Breathe And Sit On Their Own & Keep Improving Your Life

Duration: 10 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: ZOLGENSMA Is The 2nd FDA Approved Treatment For SMA & Speech Generating Devices For Children

Duration: 17 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: New Method To Evaluate Children's Nutritional Status & Pending Approval of Zolgensma

Duration: 11 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Spinraza and ZOLGENSMA Improve Lives of Kids With SMA & Accomplishing Your Goals

Duration: 5 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Novartis to Open, at FDA Request, New Trial of Zolgensma for Older Patients

Duration: 7 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Biogen is Planning to Launch a First Trial, Testing Spinraza in Children Previously Given Zolgensma

Duration: 6 min

Health Care Rounds

Series: Health Care Rounds

Episode: #65: Our Take, August 12, 2019

Duration: 9 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: How Zolgensma Could Be More Cost-Effective Than Spinraza & How Much We've Changed in 10 Years

Duration: 12 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Zolgensma Extends Survival in SMA Type 1 Patients Years After Dosing & How Will SMA Change

Duration: 10 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Additional Space For Zolgensma Production With AveXis Catalent Partnership & Trending Topics

Duration: 4 min

Industry Focus

Series: Industry Focus

Episode: Healthcare: Is Zolgensma's $2.1 Million Price Tag Ridiculous?

Duration: 23 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: SMA Type 1 Infants Treated With Zolgensma Achieving Milestones, Data Show

Duration: 7 min

Pharma Intelligence Podcasts

Series: Pharma Intelligence Podcasts

Episode: Chloroquine’s EUA, new FDA coronavirus treatment accelerator, No Penalties for Zolgensma

Duration: 27 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Ohio Study Finds Zolgensma Safe and Effective, Particularly in Younger Infants

Duration: 6 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Discussing Motor Gains and Safety with Zolgensma’s IT Use in a STRONG Trial

Duration: 9 min

Health Professional Radio - Podcast

Series: Health Professional Radio - Podcast

Episode: First Gene Therapy for Spinal Muscular Atrophy

Duration: 8 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: Ideas for Staying Fit and Healthy During Isolation & Approval of Zolgensma for Treating SMA in Japan

Duration: 5 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: MDA Conference Brought Neuromuscular Experts Together & What To Ask About Zolgensma?

Duration: 8 min

SMA News & Perspectives

Series: SMA News & Perspectives

Episode: 100 Free Zolgensma Treatments Worldwide in 2020 & Unplugging the iPad, Waste of Time

Duration: 8 min